IP Library › Assignment 064960/0757
Patent Assignment
Reel/Frame 064960/0757

Security Interest

Recorded: 2023-09-19 Pages: 8
Assignors
PELICAN TECHNOLOGY HOLDINGS, INC.
Executed: 2023-09-18
PRIMROSE BIO, INC.
Executed: 2023-09-18
Assignee
LIGAND PHARMACEUTICALS INCORPORATED
3911 SORRENTO VALLEY BOULEVARD, SUITE 110, SAN DIEGO, CALIFORNIA, 92121
Covered Property (1)
High Level Expression of Recombinant Toxin Proteins
Patent: 8,530,171 →
Application: 13/073,955 →
Publication: US 2011/0287443
Related Assignments (1)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 3, 2023
From: PFENEX INC.
To: PELICAN TECHNOLOGY HOLDINGS, INC.
Reel/Frame 065107/0666 →